
Abeona Therapeutics ABEO
€ 4.61
0.33%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Abeona Therapeutics P/S 2011-2025 | ABEO
P/S Jährlich Abeona Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.7 | 15.5 | 0.341 | 17.7 | - | 104 | 761 | 177 | 69.3 | 6.6 | 4.45 | 2.58 | 14.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 761 | 0.341 | 101 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.75 | -0.84 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.02 | -0.66 % | $ 233 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.22 | 23.66 % | $ 479 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 1.16 | -1.28 % | $ 6.33 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 209.08 | -1.75 % | $ 5 B | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 26.17 | -2.46 % | $ 1.69 M | ||
|
Aptevo Therapeutics
APVO
|
3.11 | $ 0.56 | -40.06 % | $ 155 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.15 | 1.78 % | $ 7.58 B | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 94.08 | -1.0 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.92 | 0.41 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 9.49 | 0.13 % | $ 139 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Dynavax Technologies Corporation
DVAX
|
6.24 | $ 15.4 | 0.1 % | $ 2 B | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
19.1 | $ 586.59 | -0.77 % | $ 44.4 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Eton Pharmaceuticals
ETON
|
3.61 | $ 16.76 | -1.38 % | $ 430 M | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 1.03 | -1.9 % | $ 27.9 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.47 | -2.37 % | $ 15.5 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 92.63 | 0.19 % | $ 96.9 B | ||
|
Exelixis
EXEL
|
4.38 | $ 46.5 | -0.03 % | $ 13.5 B | ||
|
Foghorn Therapeutics
FHTX
|
11.1 | $ 5.38 | -0.37 % | $ 295 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 12.48 | 0.89 % | $ 822 M |